Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors
Authors:
- 1 January 2019
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 81 (3) , 59-65
Abstract
The paper is devoted to changes in the 4th edition of the WHO classification of lymphoid tumors in the 2017 revision, to the principles of the structure and features of the classification. It discusses changes in the identification of new clinical and morphological categories and in the abolition of some previously existing ones. New information about lymphoid tumors, their immunophenotypic and molecular characteristics of classification importance are briefly outlined. The absolute need for molecular genetic studies for the diagnosis of certain lymphoproliferative diseases is underlined. The characteristics of lymphoid pretumor states are given.Keywords
This publication has 79 references indexed in Scilit:
- The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and MicroenvironmentBioMed Research International, 2013
- In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behaviorHaematologica, 2011
- Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphomaBlood, 2011
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesBlood, 2011
- Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entityHaematologica, 2010
- A novel subset of T-helper cells: follicular T-helper cells and their markersHaematologica, 2010
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancerBreast Cancer Research, 2008
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007